Nurix Therapeutics (NRIX) News Today $10.14 +0.63 (+6.62%) Closing price 05/20/2025 04:00 PM EasternExtended Trading$10.10 -0.04 (-0.35%) As of 08:30 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRIX Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 Time Period Velan Capital Investment Management LP Invests $1.84 Million in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Velan Capital Investment Management LP bought a new stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 97,889 shares of the company's stock, valued at approximately $1,844May 21 at 8:23 AM | marketbeat.comVestal Point Capital LP Acquires 60,000 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)Vestal Point Capital LP lifted its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 14.1% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 485,000 shares of the company's stock after purchasiMay 21 at 8:23 AM | marketbeat.comSoleus Capital Management L.P. Raises Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Soleus Capital Management L.P. lifted its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 97.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,102,833 shares of the company's stock after buying an addiMay 21 at 8:07 AM | marketbeat.comPoint72 Asset Management L.P. Takes $16.45 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Point72 Asset Management L.P. acquired a new stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 872,959 shares of the company's stock, valued at approximately $16,447,000. Point72 AMay 20 at 5:30 AM | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Deutsche Bank AGDeutsche Bank AG cut its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 37.8% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 531,197 shares of the company's stock after selling 323,485 shaMay 19 at 3:57 AM | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Acquired by Northern Trust CorpNorthern Trust Corp lifted its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 16.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 659,788 shares of the company's stock after buyinMay 19 at 3:18 AM | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives $30.44 Average PT from BrokeragesMay 19 at 1:33 AM | americanbankingnews.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Recommendation of "Moderate Buy" by AnalystsShares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) have been given an average recommendation of "Moderate Buy" by the nineteen brokerages that are presently covering the company, Marketbeat reports. Three investment analysts have rated the stock with a hold rating and sixteen have aMay 18 at 2:22 AM | marketbeat.com229,369 Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX) Acquired by Jacobs Levy Equity Management Inc.Jacobs Levy Equity Management Inc. bought a new position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The firm bought 229,369 shares of the company's stock, valued at approximately $4,321,0May 17, 2025 | marketbeat.comNurix Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)May 16, 2025 | globenewswire.comParkman Healthcare Partners LLC Purchases 93,201 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)Parkman Healthcare Partners LLC raised its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 21.2% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 532,172 shares of the company's stock after buyingMay 16, 2025 | marketbeat.comPatient Square Capital LP Acquires 120,507 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)Patient Square Capital LP grew its holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 37.0% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 446,296 shares of the company's stock after purchasing an additional 1May 16, 2025 | marketbeat.comEnsign Peak Advisors Inc Increases Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Ensign Peak Advisors Inc lifted its holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 108.2% during the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 374,673 shares of the company's stock after buying an additMay 16, 2025 | marketbeat.comNurix Therapeutics to Participate in the RBC Capital Markets Global Healthcare ConferenceMay 15, 2025 | globenewswire.comNurix Therapeutics Announces Presentations of Clinical Data at the 30th European Hematology Association Congress and the 18th International Conference on Malignant LymphomaMay 14, 2025 | globenewswire.comIntegral Health Asset Management LLC Acquires 50,000 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)Integral Health Asset Management LLC lifted its holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 25.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 250,000 shares of the company's stockMay 14, 2025 | marketbeat.comCubist Systematic Strategies LLC Invests $2.34 Million in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Cubist Systematic Strategies LLC purchased a new position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund purchased 124,025 shares of the company's stock, valued at approxiMay 14, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Stock Position Reduced by Deep Track Capital LPDeep Track Capital LP decreased its position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 22.4% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 3,000,000 shares of the company's stockMay 9, 2025 | marketbeat.comVoya Investment Management LLC Has $1.04 Million Stock Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Voya Investment Management LLC grew its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 171.8% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,079 shares of the company's stock afterMay 9, 2025 | marketbeat.comFirst Trust Advisors LP Acquires New Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)First Trust Advisors LP bought a new position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 135,903 shares of the company's stock, valuMay 7, 2025 | marketbeat.comRaymond James Financial Inc. Takes Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Raymond James Financial Inc. bought a new position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 54,453 shares of the company's stock, valued at approximatelyMay 7, 2025 | marketbeat.comBoxer Capital Management LLC Acquires New Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Boxer Capital Management LLC bought a new position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor bought 563,067 shares of the company's stock,May 4, 2025 | marketbeat.comSchonfeld Strategic Advisors LLC Grows Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Schonfeld Strategic Advisors LLC lifted its position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 13.3% during the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 402,955 shares of the company's stock after purchasing an additional 47,353 shares durinMay 4, 2025 | marketbeat.comInvesco Ltd. Decreases Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Invesco Ltd. trimmed its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 87.4% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 51,980 shares of the company's stock after selling 361,360 shares during the periMay 4, 2025 | marketbeat.comRA Capital Management L.P. Invests $25.12 Million in Nurix Therapeutics, Inc. (NASDAQ:NRIX)RA Capital Management L.P. bought a new stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 1,333,333 shares of the company's stock, valued atMay 3, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Sells $70,223.34 in StockMay 3, 2025 | insidertrades.comJPMorgan Chase & Co. Reduces Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)JPMorgan Chase & Co. decreased its holdings in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 54.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 30,895 shares of the company's stock after sellingMay 3, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Receives "Buy" Rating from Needham & Company LLCNeedham & Company LLC restated a "buy" rating and issued a $27.00 price target on shares of Nurix Therapeutics in a report on Tuesday.May 1, 2025 | marketbeat.comDarwin Global Management Ltd. Takes $3.08 Million Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Darwin Global Management Ltd. acquired a new position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 163,681 shares of the company's stock, valMay 1, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Sells $28,037.00 in StockMay 1, 2025 | insidertrades.comPrice T Rowe Associates Inc. MD Sells 61,634 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)Price T Rowe Associates Inc. MD cut its holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 2.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 3,007,327 shares of the company's stock after selling 61,634 shares during the periodMay 1, 2025 | marketbeat.comLord Abbett & CO. LLC Purchases 87,132 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)Lord Abbett & CO. LLC boosted its position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 24.8% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 437,772 shares of the company's stock after purchaApril 30, 2025 | marketbeat.comT. Rowe Price Investment Management Inc. Decreases Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX)T. Rowe Price Investment Management Inc. lowered its stake in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 6.6% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The fund owned 2,380,428 shares of the company's stock after selling 167,663 shaApril 29, 2025 | marketbeat.comNurix Therapeutics Presents Data at the AACR 2025 Annual Meeting Highlighting the Transformative Potential of Its Proprietary DEL-AI Platform Leveraging Machine Learning to Speed the Discovery of Novel DrugsApril 28, 2025 | globenewswire.comNurix Therapeutics reports breakthroughs in cancer drug researchApril 27, 2025 | investing.comNurix Therapeutics Presents Positive Preclinical Data at the AACR 2025 Annual Meeting from Multiple Orally Available, Brain Penetrant Degraders Against Three High Value Oncology TargetsApril 25, 2025 | globenewswire.comRussell Investments Group Ltd. Grows Stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Russell Investments Group Ltd. raised its stake in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 4,810.0% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 35,745 shares of theApril 25, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Trading 6.4% Higher - Here's What HappenedNurix Therapeutics (NASDAQ:NRIX) Trading 6.4% Higher - Here's What HappenedApril 23, 2025 | marketbeat.comJump Financial LLC Takes Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Jump Financial LLC bought a new position in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 74,619 shares of the company's stock, valuedApril 22, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Consensus Rating of "Moderate Buy" from BrokeragesShares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the nineteen ratings firms that are currently covering the stock, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and sixteen haApril 22, 2025 | marketbeat.comWasatch Advisors LP Has $11.29 Million Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Wasatch Advisors LP lessened its holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 15.4% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 599,401 shares of the coApril 19, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Bought by Geode Capital Management LLCGeode Capital Management LLC grew its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 9.5% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,585,127 shares of the company's stock aApril 19, 2025 | marketbeat.comNurix Therapeutics, Inc.: Nurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory ConditionsApril 18, 2025 | finanznachrichten.deNurix Therapeutics (NASDAQ:NRIX) Shares Gap Down - What's Next?Nurix Therapeutics (NASDAQ:NRIX) Shares Gap Down - Time to Sell?April 17, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Acquired by Affinity Asset Advisors LLCAffinity Asset Advisors LLC boosted its stake in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 9.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 940,083 shares of the company's stock after buying anApril 17, 2025 | marketbeat.comNurix Announces FDA Clearance of IND Application for GS-6791/NX-0479 - a Novel IRAK4 Degrader for Inflammatory ConditionsApril 17, 2025 | globenewswire.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Bought by Fmr LLCFmr LLC lifted its stake in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 1,711.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,634,231 shares of the company's stock after purchasing an additiApril 15, 2025 | marketbeat.comTrexquant Investment LP Reduces Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Trexquant Investment LP lowered its position in Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) by 85.9% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 22,527 shares of the company's stock after selApril 15, 2025 | marketbeat.comLeerink Partnrs Has Optimistic Outlook of NRIX Q2 EarningsNurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) - Stock analysts at Leerink Partnrs lifted their Q2 2025 EPS estimates for shares of Nurix Therapeutics in a research note issued to investors on Tuesday, April 8th. Leerink Partnrs analyst F. Khurshid now forecasts that the company will post eApril 13, 2025 | marketbeat.comNorges Bank Buys New Shares in Nurix Therapeutics, Inc. (NASDAQ:NRIX)Norges Bank bought a new stake in shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 318,800 shares of the company's stock, valuApril 12, 2025 | marketbeat.com Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address NRIX Media Mentions By Week NRIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRIX News Sentiment▼1.310.65▲Average Medical News Sentiment NRIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRIX Articles This Week▼146▲NRIX Articles Average Week Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies CRNX News SRRK News MRUS News MOR News PTGX News MLTX News IMVT News IBRX News XENE News AMRX News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRIX) was last updated on 5/21/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredSilicon Valley Gold RushA new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBuffett’s favorite chart just hit 209% – here’s what that means for goldA Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...Golden Portfolio | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
